Trials / Unknown
UnknownNCT05129813
Improving Treatment and Recovery Services for Individuals With Opioid Problems
Improving Treatment and Recovery Services for Individuals With Opioid Problems and Their Family Members
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Howard University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Participants include persons receiving buprenorphine treatment and Recovery Guide counseling in a Federally Qualified Health Center or buprenorphine treatment by telemedicine and Recovery Guide counseling in a church or faith-based community organization. Participants are interviewed at the outset of treatment, after 4 to 6 weeks, and then at 10 to 12 weeks of treatment. The study is an observational study aimed at evaluating the experiences and response to treatment of participants.
Detailed description
Participants include persons receiving buprenorphine treatment and Recovery Guide counseling in a Federally Qualified Health Center or buprenorphine treatment by telemedicine and Recovery Guide counseling in a church or faith-based community organization. Participants are interviewed at the outset of treatment, after 4 to 6 weeks, and then at 10 to 12 weeks of treatment. The study is an observational study aimed at evaluating the experiences and response to treatment of participants. Interviews use a semi-structured format assessing current and past opioid and other substance use, adherence to buprenorphine, and experiences with the counseling and other services provided.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Recovery Guide Counseling | Recovery Guide Counseling is a 12-session psychoeducational and behavioral counseling intended for delivery by Peer Recovery Specialists, community health workers, or other personnel without advanced training in counseling |
Timeline
- Start date
- 2021-10-15
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2021-11-22
- Last updated
- 2021-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05129813. Inclusion in this directory is not an endorsement.